Financials
Financial year 2025
PROPATH from Gavere, company number BE0459772872, closed financial year 2025 with a result of € 77,179 after tax. For that financial year PROPATH recorded a gross margin of € 429,875 and equity of € 599,997. Compared with financial year 2024, the result moved from € 99,646 to € 77,179. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 599,997
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 77,179
▼ 23% vs 2024
Profit after tax over the fiscal year.
€ 17,435
▼ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 581,405.
People and assets in 2025
4.1
Average over the fiscal year, from the social balance sheet.
€ 272,001
▲ 6% vs 2024
€ 66,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 88,834
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 202,979
▲ 5% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,060
▼ 1% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 245,324 | € 426,508 | € 424,898 | € 429,875 | ▲ 1% |
| Profit after taxes | € 19,295 | € 129,022 | € 99,646 | € 77,179 | ▼ 23% |
| Equity | € 294,150 | € 423,172 | € 522,818 | € 599,997 | ▲ 15% |
| Total debts | € 438,231 | € 783,187 | € 623,257 | € 343,034 | ▼ 45% |
| Cash | € 69,932 | € 20,570 | € 26,751 | € 17,435 | ▼ 35% |
| Retained profit | € 275,558 | € 404,580 | € 504,226 | € 581,405 | ▲ 15% |
| Balance sheet total | € 732,381 | € 1,206,359 | € 1,146,075 | € 943,031 | ▼ 18% |
| Employees (FTE) | 5 | 5.8 | 4.1 | 4.1 |
Key figures of PROPATH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PROPATH?
What happened at PROPATH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 77,179 (▼ 23% vs 2024). Source: NBB ↗
- Lode Maes became a director. NBB
- New establishment in Ronse. KBO
- Start of the company according to the CBE. KBO
In short
From € 19,295 profit in 2022 to € 77,179 profit in 2025.
Paid € 125,333 in corporate taxes since 2022.
Best year ever: 2023, with € 129,022 profit.
On average € 104,800 of value added per employee in 2025.
Management
The stake of DELMAC comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PROPATHBehind PROPATH is Lode Maes. The shares are held by DELMAC (100%).
Establishments
Establishment units
Physical locations of this company
Stationsstraat 215
9890 Gavere
Nieuwe Pontstraat 9
9600 Ronse
Active since 5 February 1997
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0459.772.872
- VAT number
- BE 0459.772.872
- Registered office
- Stationsstraat 215, 9890 Gavere
- Names & denominations
- PROPATH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 1997
- Peppol
- Active · Active since 4 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Vervaardiging van overige producten van metaal, neg
Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur
Groothandel in farmaceutische en medische artikelen